Would A Fixed-Term FDA Commissioner Help Industry? Maybe, Maybe Not
This article was originally published in The Gray Sheet
Executive Summary
FDA needs a commissioner position less prone to turnover every four years, said John Sheets, senior VP of corporate research at Boston Scientific.